Blog

Shares of Where Food Comes From, Inc. WFCF have declined 13.5% since the company reported its earnings for the first quarter of 2025. This compares to the S&P 500 index’s 0.5% rise over the same

Nextracker Inc. NXT is slated to report fourth-quarter fiscal 2025 results on May 14, after market close.In the last reported quarter, the company delivered an earnings surprise of 74.58%. It also

Investors in Veris Residential, Inc. VRE need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $22.50 Call had some of the highest

Plug Power Inc. PLUG reported first-quarter 2025 results, wherein its bottom line missed the Zacks Consensus Estimate.The company’s adjusted loss was 21 cents per share, wider than the consensus

Bayer AG BAYRY reported first-quarter 2025 core earnings of 66 cents per American Depositary Receipt (ADR), beating the Zacks Consensus Estimates of 63 cents. The company reported earnings of 77

Upstart Holdings UPST and Affirm Holdings AFRM are the two well-known names in the fintech industry. These fintech innovators are using artificial intelligence (AI) to upend traditional lending

Tectonic Therapeutic, Inc. (TECX) closed the last trading session at $20.71, gaining 15.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Treace Medical Concepts (TMCI) closed the last trading session at $7.20, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of Spyre Therapeutics (SYRE) have gained 14.7% over the past four weeks to close the last trading session at $14.93, but there could still be a solid upside left in the stock if short-term

Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price

Mind Medicine (MindMed) Inc. (MNMD) closed the last trading session at $6.45, gaining 16.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Shares of Intapp (INTA) have gained 7.3% over the past four weeks to close the last trading session at $56.31, but there could still be a solid upside left in the stock if short-term price targets

Shares of Honest (HNST) have gained 14.5% over the past four weeks to close the last trading session at $5.07, but there could still be a solid upside left in the stock if short-term price targets

Shares of Kemper (KMPR) have gained 12.8% over the past four weeks to close the last trading session at $65.52, but there could still be a solid upside left in the stock if short-term price targets

Inspired Entertainment (INSE) closed the last trading session at $8.17, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Centrus Energy Corp. (LEU) closed the last trading session at $94.71, gaining 46% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Beyond (BYON) have gained 30.8% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets

Shares of AudioEye (AEYE) have gained 14.3% over the past four weeks to close the last trading session at $12.90, but there could still be a solid upside left in the stock if short-term price

Shares of Easterly Government Properties (DEA) have gained 0.1% over the past four weeks to close the last trading session at $20.92, but there could still be a solid upside left in the stock if

Cogent Biosciences, Inc. (COGT) closed the last trading session at $5.13, gaining 12% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of ClearPoint Neuro, Inc. (CLPT) have gained 18.2% over the past four weeks to close the last trading session at $13.64, but there could still be a solid upside left in the stock if

Clearfield (CLFD) closed the last trading session at $36.36, gaining 37.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Ardent Health Partners, Inc. (ARDT) closed the last trading session at $14.83, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

BridgeBio Pharma (BBIO) closed the last trading session at $35.68, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of BioLife Solutions, Inc. (BLFS) have gained 8.2% over the past four weeks to close the last trading session at $23.89, but there could still be a solid upside left in the stock if